FDA Approves Cancer Biomarker Test with Two Companion Diagnostics for Targeted Therapy
The FDA approved Illumina’s oncology comprehensive test as an IVD tool, along with its first two CDx indications for cancer patients.
Read MorePosted by Andy Lundin | Aug 28, 2024 | Cancer |
The FDA approved Illumina’s oncology comprehensive test as an IVD tool, along with its first two CDx indications for cancer patients.
Read MorePosted by Andy Lundin | Aug 16, 2024 | Unknown Origin & Other Cancer Types |
Cancer Check Labs has been chosen as the exclusive provider of early cancer detection tests for Ways2Well, a regenerative medicine clinic.
Read MorePosted by Chris Wolski | Aug 7, 2024 | Respiratory Disease |
A new study has found that a blood test can predict which preterm babies will develop chronic lung disease, allowing for earlier diagnosis.
Read MorePosted by Andy Lundin | Jul 18, 2024 | Lung Cancer |
Researchers have developed a potential exhaled-breath test for lung diseases by successfully collecting lung biomarkers from human breath.
Read MorePosted by Andy Lundin | Jun 20, 2024 | Cancer |
A new study reveals that AI can detect and diagnose cancer from tissue samples with 98.2% accuracy, allowing for earlier treatment.
Read More